Powering

Microbiome

Solutions

Powering

Microbiome

Solutions

Who We Are

Evimero is an interdisciplinary company with expertise in the molecular underpinnings of how the vast unseen world of microorganisms interact with human concerns. We use principles of Systems Biology  and AI/ML to explore and better understand these relationships, in pursuit of viable applications with impact on human and animal health, agriculture, and the environment. Specifically, Evimero explores how microbiomes – the complex ecosystems of bacteria, fungi, viruses, and other microbes that live in and on all larger living things – contribute to and sustain the health of all life on Earth. Evimero promotes Applied Microbiomics, the field that brings together abstract scientific knowledge with practical applications that can improve both individual health and that of our planet, by identifying, leveraging, and commercializing new molecular insights to make targeted changes in imbalanced, or dysbiotic microbiomes that shift the ecosystem back into harmony.

Evimero’s Technology

Evimero’s Technology

At Evimero, we use our patented technology platform to rapidly discover key molecules involved in driving the undesirable outcomes of a dysbiotic microbiome, and then to neutralize those molecules and their negative effects. Our data driven platform is based on our Causal Generative Artificial Intelligence (CGAI) framework generate a high-resolution map of the critical microbiome pathways. Our technology is robust and can be applied in practically any setting, making it compatible not only with human healthcare applications but also those targeting agricultural and environmental concerns – anywhere that an imbalanced microbial ecosystem produces deleterious effects.

Integrated Platform

The Evimero Platform provides a complete solution for rapid response to new and emerging infectious diseases from laboratory identification to diagnostic and therapeutic development that will be manufactured in the United States. With our platform approach, the development time can be reduced by ¼  and development cost can be reduced by 2 orders of magnitude compared to traditional drug discovery.

Contact Us

Evimero’s microbiome technology can solve many of the world’s most challenging health and environmental problems.